// App-Quantinova.ai

1066 : Synthetic miR-22 inhibits alternative non homologous end-joining DNA repair and increases sensitivity to PARP-inhibition in multiple myeloma cells

Researchers

Presenter

  • Daniele Caracciolo

Principal Investigators

  • Eugenio Morelli

  • Maria Teresa Di Martino

  • Daniela Talarico

  • Cirino Botta

  • Nicola Amodio

  • Cinzia Federico

  • Emanuela Altomare

  • Lavinia Biamonte

  • Maria Angelica Stamato

  • Pierosandro Tagliaferri

  • Pierfrancesco Tassone

Medical Centers

  • UMG of Catanzaro, Catanzaro, Italy.

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Multiple Myeloma

  • Solid malignancies

Biomarkers

  • Poly(ADP-Ribose) Polymerase 1

  • DNA Polymerase Theta

  • Leucine Rich Repeats And Immunoglobulin Like Domains 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved